about
Biomarkers and Targeted Therapy in Pancreatic CancerCirculating DNA and Micro-RNA in Patients with Pancreatic Cancer.Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review.CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma.Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model.KRAS induces lung tumorigenesis through microRNAs modulation.A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
P2860
Q26752755-D8C2CF77-CE69-4D7D-AA47-6805FDD4ECF2Q35828060-B8C59114-5DE5-4F9E-AA08-2947573E18FAQ36249508-0C2B8844-FE8D-4699-98B8-84547DBCB3DEQ38406521-22940887-13CA-4F1E-B9B4-812C4790667DQ39070481-9BD7158D-1667-4C5F-92A3-99C1EA23D930Q47093825-FEB11D11-3443-498C-BA1A-0F9DF13D11A5Q49296229-CBB2AB87-F02A-4B09-AF54-85148CBA388DQ50025863-57E7FFC3-9835-40F4-BCA8-6C4BCF676208Q51732438-6B6E9BDE-62DC-4BCB-83CE-64309525BC77Q54980764-A39B5758-D87F-4CF6-A386-45E56FFC96C2Q55263196-53FE74ED-B3DD-49B6-97FE-9E9B327CC763
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Allelic ratio of KRAS mutations in pancreatic cancer.
@en
Allelic ratio of KRAS mutations in pancreatic cancer.
@nl
type
label
Allelic ratio of KRAS mutations in pancreatic cancer.
@en
Allelic ratio of KRAS mutations in pancreatic cancer.
@nl
prefLabel
Allelic ratio of KRAS mutations in pancreatic cancer.
@en
Allelic ratio of KRAS mutations in pancreatic cancer.
@nl
P2860
P1433
P1476
Allelic ratio of KRAS mutations in pancreatic cancer.
@en
P2093
Albrecht Stenzinger
Jochen K Lennerz
P2860
P356
10.1634/THEONCOLOGIST.2014-0408
P577
2015-03-16T00:00:00Z